The following planners and faculty have indicated (a) relevant financial relationship(s) with an ACCME-defined ineligible company, also known as a commercial interest.
All relevant financial relationships have been mitigated. All others in control of content have indicated no relevant financial relationship with an ACCME-defined commercial interest. All clinical content presented will be evidence-based and unbiased.
| Planners and Faculty Names | Name of Commercial Interest | Nature of Relationship |
| Rohit Aggarwal, MD | Alexion | Consulting |
| ANI Pharmaceuticals | Consulting | |
| Argenx | Consulting | |
| Artasome | Consulting | |
| AstraZeneca | Consulting | |
| Boehringer-Ingelheim | Consulting, Research | |
| Bristol Myers-Squibb | Consulting, Research | |
| CabalettaBio | Consulting | |
| Capella Bioscience | Consulting | |
| Capstanx | Consulting | |
| Corbus | Consulting | |
| CSL Behring | Consulting | |
| EMD Serono | Consulting, Research | |
| Galapagos | Consulting | |
| Horizon Therapeutics | Consulting | |
| I-Cell | Consulting | |
| Immunovant | Consulting | |
| Janssen | Consulting, Research | |
| Kezar | Consulting | |
| Kyverna | Consulting | |
| Lilly | Consulting | |
| Manta Medicines Corporation | Consulting | |
| Novartis | Consulting | |
| Nuvig Therapeutics | Consulting | |
| Nkarta | Consulting | |
| Octapharma | Consulting | |
| Pfizer | Consulting, Research | |
| PRoivant | Consulting, Research | |
| Teva | Consulting | |
| Tourmaline Bio | Consulting | |
| Verismo Therapeutics | Consulting | |
| Atul Deodhar, MD | Bristol Myers Squibb | Researcher, Consultant |
| Eli Lilly | Researcher, Consultant | |
| J&J | Researcher, Consultant | |
| MoonLake | Researcher | |
| Novartis | Researcher, Consultant | |
| Pfizer | Researcher, Consultant | |
| UCB | Researcher, Consultant | |
| Bart Duell, MD | Esperion | Consultant |
| Ionis | Consultant | |
| Novo-Nordisk | Consultant | |
| Regeneron | Consultant | |
| Retrophin | Consultant | |
| New Amsterdam | Consultant | |
| Daniela Ghetie, MD | Amgen | Consulting Fee – Advisory Board |
| Carol Langford, MD | Bristol Myers-Squibb | Investigator |
| AstraZeneca | Investigator | |
| GlaxoSmithKline | Investigator | |
| NS Pharma | Investigator | |
| Richard Maziarz, MD | Novartis | Consultant |
| Artiva Bio | Scientific Advisory Committee | |
| Vor Pharma | DSMB Chair | |
| Oricel Therapeutics | Scientific Advisory Committee | |
| Century Therapeutics | DSMB Chair | |
| Arcellx | Advisory Board | |
| Kite Therapeutics/Gilead | Advisory Board | |
| BMS | Independent Contractor | |
| Gamida | Independent Contractor | |
| OrcaBio | Independent Contractor | |
| Eric Orwoll, MD | Biocon | Consulting |
| Amgen | Consulting | |
| Angitia | Consulting | |
| AstraZeneca | Consulting | |
| Radius | Consulting | |
| Jeff Robinson, MD | Gossamer Bio | Clinical Trial/Scientific Consulting |
| Janessen | Clinical Trial | |
| Merck | Clinical Trial | |
| United Therapeutics | Clinical Trial | |
| Jim Rosenbaum, MD | Corvus Pharmaceuticals | VP (now retired) |